Log In
Print
BCIQ
Print
Print this Print this
 

MDCO-216 (formerly ET-216)

Also known as: ApoA-1 Milano (formerly ETC-216)

  Manage Alerts
Collapse Summary General Information
Company The Medicines Co.
DescriptionComplex of dimeric recombinant apolipoprotein A-1 Milano and a phospholipid
Molecular Target Cholesterol
Mechanism of ActionCholesterol removal
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase I
Standard IndicationAtherosclerosis
Indication DetailsTreat atherosclerosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$10.0M

$410.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today